Details for New Drug Application (NDA): 202552
✉ Email this page to a colleague
The generic ingredient in ACITRETIN is acitretin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acitretin profile page.
Summary for 202552
Tradename: | ACITRETIN |
Applicant: | Impax Labs Inc |
Ingredient: | acitretin |
Patents: | 0 |
Suppliers and Packaging for NDA: 202552
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACITRETIN | acitretin | CAPSULE;ORAL | 202552 | ANDA | Amneal Pharmaceuticals of New York LLC | 0115-1750 | 0115-1750-08 | 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1750-08) |
ACITRETIN | acitretin | CAPSULE;ORAL | 202552 | ANDA | Amneal Pharmaceuticals of New York LLC | 0115-1751 | 0115-1751-08 | 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1751-08) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Dec 23, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 17.5MG | ||||
Approval Date: | Dec 23, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 22.5MG | ||||
Approval Date: | Dec 23, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription